嘉和生物与亿腾医药达成“史诗级”合并协议

新浪财经
27 Dec 2024

近日,嘉和生物与亿腾医药宣布了一项具有里程碑意义的战略合并协议。此次被誉为“史诗级”交易的合并,不仅将标志着港股市场首例反向并购案例的诞生,更将为 医药生物 板块注入强劲的 新动力 。合并后的新实体公司预计将命名为“亿腾嘉和医药集团有限公司”,市值估计将超过40亿港元,有望成为行业内的又一巨头。亿腾医药以其成熟稳定的商业模式和强大的现金流,在 生物医药 领域一直保持着强劲的发展势头。此次反向收购...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10